Immediate Impact
2 by Nobel laureates 2 from Science/Nature 68 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Daniel Tavares being referenced
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation
2019
IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel Tavares | 177 | 116 | 61 | 11 | 288 | |
| Leanne Lanieri | 171 | 133 | 84 | 17 | 274 | |
| Neil Atkey | 179 | 82 | 98 | 14 | 283 | |
| Lipai Chen | 115 | 27 | 129 | 9 | 284 | |
| Carlos Hernández | 169 | 22 | 98 | 15 | 305 | |
| Yue Ma | 104 | 18 | 112 | 12 | 264 | |
| Jacques Mauillon | 131 | 57 | 57 | 11 | 305 | |
| Thong Quang Pham | 50 | 40 | 72 | 11 | 318 | |
| Federica Predolini | 143 | 44 | 77 | 12 | 267 | |
| Joseph W. Po | 140 | 20 | 105 | 14 | 296 | |
| Noah Richardson | 178 | 57 | 61 | 12 | 313 |
All Works
Login with ORCID to disown or claim papers
Loading papers...